p.98 抽出テキスト

142. Carvajal HG, Callahan CP, Miller JR, et al. Cardiac Surgery in Trisomy 13 and 18: A Guide to Clinical Decision-Making. Pediatr Cardiol 2020; 41: 1319-1333. PMID: 32924070 143. Valentin LI, Perez L, Masand P. Hepatoblastoma Associated with Trisomy 18. J Pediatr Genet 2015; 4: 204-206. PMID: 27617134 144. Nishi E, Takamizawa S, Iio K, et al. Surgical intervention for esophageal atresia in patients with trisomy 18. Am J Med Genet A 2014; 164A: 324-330. PMID: 24311518 145. Baty BJ, Blackburn BL, Carey JC. Natural history of trisomy 18 and trisomy 13: I. Growth, physical assessment, medical histories, survival, and recurrence risk. Am J Med Genet 1994; 49: 175-188. PMID: 8116665 146. Jones KL, Jones MC, Campo MD. Trisomy 13 syndrome. In: Jones KL, Jones MC, Campo MD. Smith’s recognizable patterns of human malformation, 8th edn. Elsevier, 2022: 14-17. 147. Nishi E, Takasugi M, Kawamura R, et al. Clinical courses of children with trisomy 13 receiving intensive neonatal and pediatric treatment. Am J Med Genet A 2018; 176: 1941- 1949. PMID: 30152146 148. Gravholt CH, Viuff MH, Brun S, et al. Turner syndrome: mechanisms and management. Nat Rev Endocrinol 2019; 15: 601-614. PMID: 31213699 149. Bernard V, Donadille B, Zenaty D, et al. CMERC Center for Rare Disease. Spontaneous fertility and pregnancy outcomes amongst 480 women with Turner syndrome. Hum Reprod 2016; 31: 782-788. PMID: 26874361 150. Corbitt H, Morris SA, Gravholt CH, et al. GenTAC Registry Investigators. TIMP3 and TIMP1 are risk genes for bicuspid aortic valve and aortopathy in Turner syndrome. PLoS Genet 2018; 14: e1007692. PMID: 30281655 151. Mittal S, Breckpot J. Genetic aspects of congenital heart defects. In: Robert ES, Penny DJ, Feltes TF, et al. Moss and Adams’ Heart disease in infants, children and adolescents, 10th edn. Wolters Kluwer, 2022: 84-112. 152. Gravholt CH, Landin-Wilhelmsen K, Stochholm K, et al. Clinical and epidemiological description of aortic dissection in Turner’s syndrome. Cardiol Young 2006; 16: 430-436. PMID: 16984695 153. Jones L, Blair J, Hawcutt DB, et al. Hypertension in Turner syndrome: a review of proposed mechanisms, management and new directions. J Hypertens 2023; 41: 203-211. PMID: 36583347 154. Gajecka M, Mackay KL, Shaffer LG. Monosomy 1p 36 deletion syndrome. Am J Med Genet C Semin Med Genet 2007; 145C: 346-356. PMID: 17918734 155. Jacquin C, Landais E, Poirsier C, et al. 1p 36 deletion syndrome: Review and mapping with further characterization of the phenotype, a new cohort of 86 patients. Am J Med Genet A 2023; 191: 445-458. PMID: 36369750 156. Battaglia A, Carey JC, South ST. Wolf-Hirschhorn syndrome: A review and update. Am J Med Genet C Semin Med Genet 2015; 169: 216-223. PMID: 26239400 157. Zollino M, Lecce R, Fischetto R, et al. Mapping the Wolf- Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. Am J Hum Genet 2003; 72: 590-597. PMID: 12563561 158. Shimizu K, Wakui K, Kosho T, et al. Microarray and FISH-based genotype-phenotype analysis of 22 Japanese patients with Wolf- Hirschhorn syndrome. Am J Med Genet A 2014; 164A: 597-609. PMID: 24357569 159. Nguyen JM, Qualmann KJ, Okashah R, et al. 5p deletions: Current knowledge and future directions. Am J Med Genet C Semin Med Genet 2015; 169: 224-238. PMID: 26235846 160. Kondoh T, Shimokawa O, Harada N, et al. Genotype-phenotype correlation of 5p-syndrome: pitfall of diagnosis. J Hum Genet 2005; 50: 26-29. PMID: 15602631 161. Spinner NB, Gilbert MA, Loomes KM, et al. Alagille syndrome. GeneReviews®. https://www.ncbi.nlm.nih.gov/books/NBK1273/ 162. Turnpenny PD, Ellard S. Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 2012; 20: 251- 257. PMID: 21934706 163. Plein A, Calmont A, Fantin A, et al. Neural crest-derived SEMA3C activates endothelial NRP 1 for cardiac outflow tract septation. J Clin Invest 2015; 125: 2661-2676. PMID: 26053665 164. Randall V, McCue K, Roberts C, et al. Great vessel development requires biallelic expression of Chd7 and Tbx1 in pharyngeal ectoderm in mice. J Clin Invest 2009; 119: 3301- 3310. PMID: 19855134 165. Van Nostrand JL, Brady CA, Jung H, et al. Inappropriate p 53 activation during development induces features of CHARGE syndrome. Nature 2014; 514: 228-232. PMID: 25119037 166. Schulz Y, Wehner P, Opitz L, et al. CHD 7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance. Hum Genet 2014; 133: 997-1009. PMID: 24728844 167. van Ravenswaaij-Arts C, Martin DM. New insights and advances in CHARGE syndrome: Diagnosis, etiologies, treatments, and research discoveries. Am J Med Genet C Semin Med Genet 2017; 175: 397-406. PMID: 29171162 168. Corsten-Janssen N, Scambler PJ. Clinical and molecular effects of CHD 7 in the heart. Am J Med Genet C Semin Med Genet 2017; 175: 487-495. PMID: 29088513 169. Fan C, Liu M, Wang Q. Functional analysis of TBX 5 missense mutations associated with Holt-Oram syndrome. J Biol Chem 2003; 278: 8780-8785. PMID: 12499378 170. Collavoli A, Hatcher CJ, He J, et al. TBX5 nuclear localization is mediated by dual cooperative intramolecular signals. J Mol Cell Cardiol 2003; 35: 1191-1195. PMID: 14519429 171. McDermott DA, Fong JC, Basson CT. Holt-Oram syndrome. GeneReviews

®. https://www.ncbi.nlm.nih.gov/books/NBK1111/ 172. Miyake N, Koshimizu E, Okamoto N, et al. MLL 2 and KDM 6A mutations in patients with Kabuki syndrome. Am J Med Genet A 2013; 161A: 2234-2243. PMID: 23913813 173. Adam MP, Hudgins L, Hannibal M. Kabuki syndrome. GeneReviews®. https://www.ncbi.nlm.nih.gov/books/NBK62111/ 174. Aoki Y, Niihori T, Inoue S, et al. Recent advances in RASopathies. J Hum Genet 2016; 61: 33-39. PMID: 26446362 175. Aoki Y, Niihori T, Narumi Y, et al. The RAS/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders. Hum Mutat 2008; 29: 992-1006. PMID: 18470943 176. Raaijmakers R, Noordam C, Noonan JA, et al. Are ECG abnormalities in Noonan syndrome characteristic for the syndrome? Eur J Pediatr 2008; 167: 1363-1367. PMID: 18270737 177. Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 1998; 281: 108-111. PMID: 9651244 178. Benson DW, Silberbach GM, Kavanaugh-McHugh A, et al. Mutations in the cardiac transcription factor NKX 2. 5 affect diverse cardiac developmental pathways. J Clin Invest 1999; 104: 1567- 1573. PMID: 10587520 179. Goldmuntz E, Geiger E, Benson DW. NKX 2. 5 mutations in patients with tetralogy of fallot. Circulation 2001; 104: 2565- 2568. PMID: 11714651 180. McElhinney DB, Geiger E, Blinder J, et al. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol 2003; 42: 1650-1655. PMID: 14607454 181. Stallmeyer B, Fenge H, Nowak-Göttl U, et al. Mutational spectrum in the cardiac transcription factor gene NKX 2. 5 (CSX) associated with congenital heart disease. Clin Genet 2010; 78: 533- 540. PMID: 20456451 182. Ellesøe SG, Johansen MM, Bjerre JV, et al. Familial Atrial Septal Defect and Sudden Cardiac Death: Identification of a Novel NKX2-5 Mutation and a Review of the Literature. Congenit Heart Dis 2016; 11: 283-290. PMID: 26679770 183. Akçaboy MI, Cengiz FB, Inceoğlu B, et al. The effect of p.Arg25Cys alteration in NKX2-5 on conotruncal heart anomalies: mutation or polymorphism? Pediatr Cardiol 2008; 29: 126- 129. PMID: 17891434 184. Okubo A, Miyoshi O, Baba K, et al. A novel GATA 4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet 2004; 41: e97. PMID: 15235040 185. Hirayama-Yamada K, Kamisago M, Akimoto K, et al. Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A 2005; 135: 47-52. PMID: 15810002 186. Sarkozy A, Conti E, Neri C, et al. Spectrum of atrial septal defects associated with mutations of NKX 2. 5 and GATA 4 transcription factors. J Med Genet 2005; 42: e16. PMID: 15689439 187. Tomita-Mitchell A, Maslen CL, Morris CD, et al. GATA4 sequence variants in patients with congenital heart disease. J Med Genet 2007; 44: 779-783. PMID: 18055909 188. Kodo K, Nishizawa T, Furutani M, et al. GATA 6 mutations cause human cardiac outflow tract defects by disrupting semaphorin-plexin signaling. Proc Natl Acad Sci U S A 2009; 106: 13933- 13938. PMID: 19666519 189. Maitra M, Koenig SN, Srivastava D, et al. Identification of GATA6 sequence variants in patients with congenital heart defects. Pediatr Res 2010; 68: 281-285. PMID: 20581743 190. Škorić-Milosavljević D, Tjong FVY, Barc J, et al. GATA 6 mutations: Characterization of two novel patients and a comprehensive overview of the GATA6 genotypic and phenotypic spectrum. Am J Med Genet A 2019; 179: 1836-1845. PMID: 31301121 191. Sharma A, Wasson LK, Willcox JA, et al. Pediatric Cardiac Genomics Consortium. GATA 6 mutations in hiPSCs inform